MiniMed Group, Inc. Common Stock

NASDAQ:MMED

Medical - Care Facilities

Healthcare
$16.99 +2.63%

+$0.40 today

Market cap
$4.78B
Beta
-3.63
P/E (TTM)
-14.2
EPS (TTM)
-$1.91
52W Low $10.65High $20.48

Volume 4.70M

Average 0.95M

MMED Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

MiniMed Group, Inc. Common StockNASDAQ: MMED

Gross Profit · Q1 FY2026 · quarter ended Jul 2026

Gross profit of $465M in Q1 FY2026

Q1 FY2026 gross profit was $465M. Trailing-twelve-month gross profit was $1.74B. Over 3 fiscal years it compounded at +8.7% a year.

Context

  • Gross profit amounted to 54.2% of revenue in FY2025, down 2.0 pp from a year earlier.
  • Gross profit increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly gross profit holds near $465M or moves back toward the trailing-twelve-month quarterly average of $433.75M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJul 2026
$465M-3.1% QoQ
Last fiscal yearApr 2026
$1.68B+10.2% YoY
LTMJul 2026
$1.74B— YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year+10.2%——
3-year CAGR+8.7%——
5-year CAGR——
10-year CAGR——

Gross Profit history

USD · from the income statement

Latest · FY2025
1.68B USD
Year-over-year change
+10.2%
3-year CAGR
+8.7%

Gross Profit vs competitors

How MMED compares with its peers on the latest reported figures

  • MMED's LTM Jul 2026 gross profit of $1.74B is the 4th highest of the 7 companies compared; the peer median is $1.37B.
  • Gross profit amounts to 53.8% of revenue for MMED, versus a peer median of 59.8%.
MMED Competitors Peer median
Gross Profit for MMED and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MDTMedtronic plcLTM Jul 2026$25.04B +15.4%+4.9%66.7%
DXCMDexCom, Inc.LTM Jun 2026$3.1B +22.8%+14.2%62.5%
PODDInsulet CorporationLTM Jun 2026$2.17B +30.0%+34.0%71.1%
MMEDMiniMed Group, Inc. Common StockLTM Jul 2026$1.74B —+8.7%53.8%
TNDMTandem Diabetes Care, Inc.LTM Mar 2026$564.4M +10.0%+8.7%54.9%
BBNXBeta Bionics, Inc.LTM Mar 2026$63M +67.3%+577.0%57.2%
SENSSenseonics Holdings, Inc.LTM Mar 2026$21.2M +1144.7%+79.5%52.1%
MMEDVMiniMed Group, Inc.—— ———
Peer median (excluding MMED) $1.37B+26.4%+24.1%59.8%

Competitors are the stored peer set for MMED. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Apr 2023
FY2023
Apr 2024
FY2024
Apr 2025
FY2025
Apr 2026
Revenue2.25B2.47B2.72B3.1B
Cost of Revenue937M1.03B1.19B1.42B
Gross Profit1.31B1.44B1.53B1.68B
Gross Margin58.3%58.2%56.2%54.2%
Research & Development429M437M438M448M
Selling, General & Admin960M1.06B1.13B1.18B
Operating Expenses1.38B1.51B1.73B1.63B
Depreciation & Amortization115M129M143M156M
EBITDA39M59M107M205M
EBITDA Margin1.7%2.4%3.9%6.6%
Operating Income(69M)(69M)(202M)49M
Operating Margin-3.1%-2.8%-7.4%1.6%
Interest Income0000
Interest Expense0000
Other Income / Expenses(7M)(1M)(1M)(236M)
Income Before Tax(76M)(70M)(203M)(187M)
Pre-Tax Margin-3.4%-2.8%-7.5%-6.0%
Income Tax Expense16M38M48M128M
Net Income(96M)(112M)(250M)(331M)
Net Margin-4.3%-4.5%-9.2%-10.7%
EPS (Basic)(0.34)(0.40)(0.89)(1.29)
EPS (Diluted)(0.34)(0.40)(0.89)(1.29)
Weighted Avg Shares280.81M280.81M280.81M256.6M
Weighted Avg Shares (Diluted)280.81M280.81M280.81M256.6M

MiniMed Group, Inc. Common Stock

NASDAQ:MMED

Intrinsic Alpha fair value

Locked

Current Price

$16.99

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.